Quantum Biopharma (QNTM) Receivables (2018 - 2025)
Quantum Biopharma (QNTM) reported Receivables of $462106.0 for Q4 2025, down 38.33% on a YoY basis from $749356.0 in Q4 2024, and down 38.33% sequentially from $749356.0 in Q4 2024.
Quantum Biopharma (QNTM) Receivables (2018 - 2025) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Receivables data on file, last reported at $462106.0 in Q4 2025.
- For the quarter ending Q4 2025, Receivables fell 38.33% year-over-year to $462106.0; the trailing twelve-month figure through Dec 2025 stood at $462106.0 (down 38.33% YoY), and the FY2025 full-year result was $462106.0, down 38.33% from the prior year.
- Receivables retreated to $462106.0 in Q4 2025, from $749356.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $749356.0 in Q4 2024 to a low of $130709.0 in Q2 2021.
- A 5-year average of $425148.5 and a median of $429229.5 in 2021 frame the typical range for Receivables.
- Across the five-year window, Receivables sank 93.4% in 2021 and jumped 227.57% in 2024, its largest moves.
- Tracing QNTM's Receivables over 5 years: stood at $500964.0 in 2021, then surged by 49.46% to $748754.0 in 2022, then slumped by 69.45% to $228764.0 in 2023, then jumped by 227.57% to $749356.0 in 2024, then tumbled by 38.33% to $462106.0 in 2025.
- Business Quant data shows QNTM's Receivables at $462106.0 in Q4 2025, $749356.0 in Q4 2024, and $228764.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Quantum Biopharma | 2.61 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 462,106.00 |
| Dec 31, 2024 | 749,356.00 |
| Dec 31, 2023 | 228,764.00 |
| Dec 31, 2022 | 748,754.00 |
| Dec 31, 2021 | 500,964.00 |
| Sep 30, 2021 | 396,353.00 |
| Jun 30, 2021 | 130,709.00 |
| Mar 31, 2021 | 184,182.00 |
| Dec 31, 2020 | 187,967.00 |
| Jun 30, 2020 | 1.98 Mn |
| Mar 31, 2020 | 1.45 Mn |
| Dec 31, 2019 | 3.14 Mn |
| Jun 30, 2019 | -244,437.62 |
| Mar 31, 2019 | 124,156.46 |
| Dec 31, 2018 | 750,792.12 |